Product Images Oxcarbazepine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 18 images provide visual information about the product associated with Oxcarbazepine NDC 72888-074 by Advagen Pharma Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Oxcarbazepine 300 mg/5 mL Oral Suspension - NDC 72888-074-14 - Carton Label - oxcarbazepine oral susp carton
Oxcarbazepine Oral Suspension is a medication used for oral use only that comes in a 250 mL bottle, and each 5 mL contains 300 mg of oxcarbazepine. The medication guide should be printed from www_advagenpharma.com/medguide/oxcarbazepine suspension and dispensed separately to each patient. The medication should be stored in the original container at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The drug should be used within 7 weeks of first opening the bottle. Before taking the drug, one should shake it well. The package insert and enclosed oxcarbazepine oral suspension instruction sheet outline the appropriate dosage. Users are advised to keep the drug out of the reach of children.*
Oxcarbazepine chemical structural. - oxcarbazepine oral susp chemical structural
Oxcarbazepine 300 mg/5 mL Oral Suspension - NDC 72888-074-14 - Carton Label - oxcarbazepine oral susp container
Each 5 ml of the product contains 300 mg of oxcarbazepine. The enclosed instruction sheet should be consulted for dosage, and the original container should be used for storage. The product should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified by USP Controlled Room Temperature. The product must be used within 7 weeks of the first opening of the bottle. It is important to keep this and all medications out of reach of children. The medication guide must be dispensed to each patient separately. The product has a volume of 250 mL and is distributed by Advagen Pharma Limited.*
Oxcarbazepine Oral Susp Figure 1. - oxcarbazepine oral susp fig 1
Oxcarbazepine Oral Susp Fig-1A - oxcarbazepine oral susp fig 1a
Oxcarbazepine Oral Susp Fig-1B - oxcarbazepine oral susp fig 1b
Oxcarbazepine Oral Susp Fig-1C - oxcarbazepine oral susp fig 1c
Oxcarbazepine Oral Susp Figure 2. - oxcarbazepine oral susp fig 2
Oxcarbazepine Oral Susp Fig-2A - oxcarbazepine oral susp fig 2a
Oxcarbazepine Oral Susp Fig-2B - oxcarbazepine oral susp fig 2b
Oxcarbazepine Oral Susp Fig-2C - oxcarbazepine oral susp fig 2c
Oxcarbazepine Oral Susp Figure 3. - oxcarbazepine oral susp fig 3
Oxcarbazepine Oral Susp Fig-3A - oxcarbazepine oral susp fig 3a
Oxcarbazepine Oral Susp Fig-3C - oxcarbazepine oral susp fig 3c
Oxcarbazepine Oral Susp Figure 4. - oxcarbazepine oral susp fig 4
Oxcarbazepine Oral Susp Fig-4C - oxcarbazepine oral susp fig 4c
Oxcarbazepine Oral Susp Fig-5C - oxcarbazepine oral susp fig 5c
Oxcarbazepine Oral Susp Fig-6C - oxcarbazepine oral susp fig 6c
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.